Journal
BRITISH JOURNAL OF CANCER
Volume 104, Issue 6, Pages 893-898Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2011.57
Keywords
miRNA; colorectal cancer; diagnostic marker; prognostic marker; single-nucleotide polymorphisms
Categories
Funding
- Institute of Digestive Disease, CUHK
Ask authors/readers for more resources
Recent researches have shed light on the biological importance of microRNAs (miRNAs) in colorectal cancer (CRC) genesis, progression and response to treatments. The potential utility of miRNAs in the preclinical stage have been explored and investigated. In this review, we explored the literature and reviewed the cutting edge progress in the discovery of noninvasive plasma and faecal miRNAs for CRC early diagnosis, as well as their measurability and predictability. We also discussed the utility of miRNAs as novel prognostic and predictive markers, and their association with CRC clinical phenotypes including recurrence, metastasis and therapeutic outcomes. Finally, we summarised miRNA- related single- nucleotide polymorphisms and their potential influence on sporadic CRC susceptibility and therapeutic response. In conclusion, the use of miRNAs as biomarker for CRC is still in its infancy and need further characterisation and evaluation. British Journal of Cancer (2011) 104, 893- 898. doi: 10.1038/bjc.2011.57www.bjcancer. com
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available